Rossari Biotech will hold a meeting of the Board of Directors of the Company on 29 April 2024.Powered by Capital Market - Live News

The Board of Rossari Biotech at its meeting held on 06 April 2024 has approved the incorporation of a wholly owned subsidiary in Dubai, United Arab Emirates in Dubai Multi Commodities Centre (DMCC) with an estimate aggregate Capital outlay of over AED 0.40 million in tranches (approximately Rs. 9.08 Million).Powered by Capital Market - Live News

Net profit of Rossari Biotech rose 33.92% to Rs 34.39 crore in the quarter ended December 2023 as against Rs 25.68 crore during the previous quarter ended December 2022. Sales rose 19.14% to Rs 463.77 crore in the quarter ended December 2023 as against Rs 389.27 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales463.77389.27 19 OPM %13.7313.92 - PBDT62.8750.63 24 PBT47.7834.67 38 NP34.3925.68 34 Powered by Capital Market - Live News

Rossari Biotech will hold a meeting of the Board of Directors of the Company on 20 January 2024.Powered by Capital Market - Live News

Net profit of Rossari Biotech rose 37.75% to Rs 32.95 crore in the quarter ended September 2023 as against Rs 23.92 crore during the previous quarter ended September 2022. Sales rose 13.64% to Rs 483.47 crore in the quarter ended September 2023 as against Rs 425.44 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales483.47425.44 14 OPM %13.1513.29 - PBDT59.9249.26 22 PBT44.8133.62 33 NP32.9523.92 38 Powered by Capital Market - Live News